A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment

NCT05916573 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Impairment

Interventions

DRUG: HSK16149

Sponsor

Haisco Pharmaceutical Group Co., Ltd.